Anti-Rheumatics Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Anti-Rheumatics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e po r t  b y  IM A R C  G r o up ,  t i t l e d  " A n t i -R h e u m a t i cs  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  a n t i - r he u m a t i c s  ma r k e t  s i z e  re a c h e d  U S $  6 4 . 5  B i l l i on  i n  2 02 3 .
R he u m a to i d  a r t h r i t i s  i s  a  ch r o n i c ,  a u t o i m mu n e  d i s e a se  t ha t  a f f e c t s  t h e  j o i n t s ,  a r t i c u l a r  
t i s su e s ,  a n d  e x t r a - a r t i c u l a r  o r g a ns .  I t  i s  a  p r o g re s s i v e  d i s o r de r  t h a t  re s u l t s  i n  p a i n ,  
Report i n f l a m m a t i o n ,  s t i f f n e s s ,  a n d  s w e l l i n g  o f  j o i n t s .  A n t i - r h e u ma t i c s  r e fe r  t o  d r u gs  u s e d  t o  
ma n a g e  d i f f e r e n t  s y m p t o m s  o f  r h e um a t o i d  a r t h r i t i s  a n d  m o d i f y  t h e  c o u r s e  o f  t h e  
d i se a s e .  T he y  c a n  b e  ad m i n i s te r e d  su b c u t an e o u s l y  ( S C ) ,  o ra l l y ,  o r  i n t ra v e n ou s l y  ( I V )  
Highlight and i n to  t h e  b o d y  o f  t h e  p a t i en t .  
A n t i - r h e um a t i cs  a r e  a l s o  u s e d  t o  t r e a t  v a r i o us  t yp e s  o f  ca n c e r ,  a n d  b o w e l ,  c o nn e c t i v e  
Description t i s su e ,  a n d  au t o i m mu n e  c o nd i t i o n s ,  su c h  a s  p s o r i a t i c  a r t h r i t i s ,  l u p u s ,  S j o g r e n  sy n d r o me  (S S ) ,  s ys te m i c  s c l e r o s i s  (S S c ) ,  an d  s y s te m a t i c  l up u s  e r y t h e m a t o s u s .  M e d i ca l  
p r a c t i t i o ne r s  u s u a l l y  p r e sc r i b e  t h e  d r u g  t o  r e du c e  pa i n ,  p r e v en t  b on e  d e f o r m i t y ,  r e du c e  
j o i n t  d a ma g e ,  p r e s e r v e  t he  s t r uc t u re  a n d  f u n c t i o n  o f  t h e  j o i n t s ,  s l ow  th e  p r o g r e ss i o n  o f  
a r t h r i t i s ,  a n d  i m p r o ve  t h e  p e r s on ’ s  o v e r a l l  f u nc t i o n .
R eq u e s t  f o r  a  P D F  sa m p l e  o f  t h i s  re p o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / a n t i - r h e um a t i cs - m a rk e t / r eq u e s t sa m p l e
Report Description
G lo b a l  A n t i - R h e u m a t ic s  M a r k e t  T r e n d s :
T h e  r i s i n g  i n c i d e n c e s  o f  r h e u m a t o i d  a r t h r i t i s ,  e s p e c i a l l y  a m o n g  t h e  s t e a d i l y  g r o w i n g  g e r i a t r i c  p o p u l a t i o n ,  a r e  c r e a t i n g  a  p o s i t i v e  
o u t l o o k  f o r  t h e  m a r k e t .  A n t i - r h e u m a t i c  d r u g s  a r e  w i d e l y  u s e d  t o  t r e a t  r h e u m a t o i d  a r t h r i t i s  a n d  i n f l a m m a t o r y  d i s e a s e s  t h a t  c a u s e  
s w e l l i n g  i n  j o i n t s  a n d  d a m a g e  t h e  e y e s ,  l u n g s  a n d  s k i n .  I n  l i n e  w i t h  t h i s ,  t h e  i n c r e a s i n g  i n c i d e n c e s  o f  o b e s i t y  d u e  t o  u n h e a l t h y  
e a t i n g  h a b i t s  a n d  c h a n g i n g  l i f e s t y l e s  o f  t h e  m a s s e s  a r e  f u r t h e r  f a v o r i n g  t h e  m a r k e t  g r o w t h .  A p a r t  f r o m  t h i s ,  r a p i d  t e c h n o l o g i c a l  
a d v a n c e m e n ts  i n  t h e  f i e l d  o f  b i o s i m i l a r s  a n d  n o v e l  b i o l o g i c  t h e r a p i e s  t h a t  a c t  f a s t e r  t h a n  c o n v e n t i o n a l  d r u g s  a n d  a r e  p r o v i d e d  i n  
c o m b i n a t i o n  w i t h  t h e  d i s e a s e - m o d i f y i n g  a n t i - r h e u m a t i c  d r u g  ( D M A R D )  t o  p a t i e n t s  a r e  p r o v i d i n g  a n  i m p e tu s  t o  t h e  m a r k e t  g r o w t h .  
M o r e o v e r ,  t h e  w i d e s p r e a d  a d o p t i o n  o f  p r e s c r i p t i o n - b a s e d  m e d i c a t i o n s  d u e  t o  t h e  i n c r e a s i n g  n u m b e r  o f  s p e c i a l i z e d  h o s p i t a l s  
w o r l d w i d e  i s  a u g m e n t i n g  t h e  m a r k e t  g r o w th .  O t h e r  f a c t o r s ,  i n c l u d i n g  t h e  r i s i n g  e x p e n d i t u r e  c a p a c i t i e s  o f  c o n s u m e r s ,  a v a i l a b i l i t y  
o f  e a r l y  d i a g n o s i s  a n d  t r e a tm e n t  o p t i o n s ,  a n d  c o n t i n u o u s  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  t o  l o w e r  t h e  s i d e  e f f e c t s  o f  
t h e  d r u g ,  a r e  a n t i c i p a t e d  t o  d r i v e  t h e  m a r k e t  t o w a r d  g r o w th .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c ip a t e d  t o  r e a c h  a  v a l u e  o f  U S $  8 0 . 4  B i l l i o n  b y  2 0 3 2 ,  g r o w i n g  a t  a  C A G R  o f  2 . 4 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / a n t i - r h e u m a t i c s - m a r k e t
Breakup by Type:
• Prescr ipt ion-based Drugs
• Over-the-Counter Drugs
 
Breakup by Drug Class:
• Disease Modifying Anti -Rheumatics Drugs 
(DMARD's)
Report • Nonsteroidal  Ant i - Infl ammatory Drugs (NSAID's)
• Cort icosteroids
Segmentation • Uric Acid Drugs
• Others
Breakup by Route of Drug 
Administration:
• Oral
• Parenteral
• Others
Breakup by Distribution Channel:
• Hospital  Pharmacies
• Retai l  Pharmacies
• E-Commerce
Breakup by Region:
Report • North America
•
Segmentation Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
Competitive • Biogen Inc.
Landscape • Bristol -Myers Squibb Company
• Cel ltr ion Inc.
with Key • El i  Li l ly and Company
Players • F. Hoff mann-La Roche AG
• Johnson & Johnsons
• Pfi zer Inc.
• Sanofi  SA
What was the size of the global anti-rheumatics 
market in 2023?
What is the expected growth rate of the global 
anti-rheumatics market during 2024-2032?
Key 
Questions What are the key factors driving the global anti-rheumatics market?
Answered in 
What has been the impact of COVID-19 on the 
the Report global anti-rheumatics market?
What is the breakup of the global anti-rheumatics 
market based on the type?
What is the breakup of the global anti-rheumatics 
market based on the drug class?
What is the breakup of the global anti-rheumatics 
market based on the route of drug administration?
What is the breakup of the global anti-rheumatics 
market based on the distribution channel?
Key 
Questions What are the key regions in the global anti-rheumatics market?
Answered in 
Who are the key players/companies in the global 
the Report anti-rheumatics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  A n t i - R h e u m a t i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     P r e s c r i p t i o n - b a s e d  D r u g s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     O v e r - t h e - C o u n t e r  D r u g s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  D r u g  C l a s s
    7 . 1     D i s e a s e  M o d i f y i n g  A n t i - R h e u m a t i c s  D r u g s  ( D M A R D ' s )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     N o n s t e r o i d a l  A n t i - I n f l a m m a t o r y  D r u g s  ( N S A I D ' s )
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     C o r t i c o s t e r o i d s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     U r i c  A c i d  D r u g s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O t h e r s
Table of         7 . 5 . 1  M a r k e t  T r e n d s        7 . 5 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  R o u t e  o f  D r u g  A d m i n i s t r a t i o n
    8 . 1     O r a l
Contents         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     P a r e n t e r a l
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O t h e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  D i s t r i b u t i o n  C h a n n e l
    9 . 1     H o s p i t a l  P h a r m a c i e s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     R e t a i l  P h a r m a c i e s
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / a n t i - rh e u ma t i c s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: